The State of the Psychedelic Industry & Open Questions (Video)

Psychedelic Alpha presents a narrated industry update that surveys the current state of psychedelic drug development and spotlights key unanswered questions. The briefing focuses on public opinion and political considerations, non-traditional access pathways, and bottlenecks to scaling medicalised delivery. It also flags “wild cards” such as intellectual property and public-private partnerships, along with international considerations. The deck includes an explicit reference point to Compass Pathways Phase 3, framed as one of several milestones that do not fully resolve broader uncertainties across development, clinical rollout, and policy.